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Abstract We investigated the sensitivity and reproducibility of a test procedure for measuring hydrogen peroxide
(H2O2) in exhaledbreath condensate and the e¡ectof storage ofthe condensate onthe H2O2 concentration, and com-
paredtheresults toprevious studies.Twentystable COPDpatientsbreathedinto ourcollectingdevicetwice for a period
of10min.The total exhaled air volume (EAV) and condensate volumeweremeasured bothtimes and the H2O2 concen-
tration of the condensatewas determined £uorimetrically.The concentrationwasmeasured again after freezing the re-
action product at 701C for a period of 10, 20 and 40 days.We collected 2^5ml condensate in 10min.The EAV and
condensate volumeswere strongly correlated.Therewas no signi¢cantdi¡erence betweenthemean H2O2 concentra-
tion of the ¢rst and second test.We obtained a detection limit for the H2O2 concentration of 0?02 mmoll
1.The H2O2
concentration appeared to remain stable for a periodup to 40 days of freezing.Compared to previous studieswe devel-
opedamore e⁄cientbreathcondensate collectingdevice andobtaineda lowerH2O2 detectionlimit.Themeasurement
of exhaled H2O2 was reproducible. In addition, storage of the samples up to 40 days showed no changes in H2O2 con-
centration.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1240, available online at http://www.idealibrary.comon
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Oxidative stress plays an important role in the develop-
ment of chronic obstructive pulmonary disease (COPD).
Oxidants may damage di¡erent cells and enzyme sys-
tems in the lungs (1,2). Oxidative stress is increased in
COPDpatients compared to healthy subjects, due to (in-
creased) exposure to exogenous oxidants such as inhaled
cigarette smoke and air pollution, or enhanced endogen-
ous production of hydrogen peroxide (H2O2) due to neu-
trophilic in£ammation and due to a relatively impaired
antioxidant system (3,4).
The degree of oxidative stress can be determined by
measuring the H2O2 concentration in exhaled breath
condensate. This is a relatively easy and non-invasive
method and re£ects the oxidative status in the lungs of
these patients.However, there are severalmethodologi-
cal issues at present, which limits its application in large
and prospective trials.Received 7 June 2001and accepted in revised form 24 October 2001.
Correspondence should be addressed to:W. J.C. van Beurden,
Catharina Hospital, Department of Pulmonology, P.O.Box1350, 5602
ZA Eindhoven,The Netherlands.Fax: +-31-40-2435149;
E-mail: w.beurden@researchlab-long.demon.nlFirstly, there is no standardizedmethod for collecting
breath condensate. The various collecting devices de-
scribed in literature collect variable amounts of breath
condensate, ranging from 1 to 5ml in 15^20min (3^13).
For the analysis at least1ml is needed. If a more e⁄cient
collecting device could be found, the collecting time
couldbe considerablyreduced,which is less inconvenient
for the patient. As such an e⁄cient collecting device is a
prerequisite.
Secondly, the H2O2 detection limit varies from study
to study; most investigators achieved a detection limit
around 0?1mmol l1. It is important to obtain a low detec-
tion limit because the H2O2 concentrationsmeasured in
previous studies were low (o1?0mmol l1) in selected
patient groups as well as in healthy control groups. In a
number of cases this was even below the detection limit
(3^13).We have tried to lower the detection limit.
Thirdly, there are limited ¢ndings on the stability of
H2O2 concentration during storage of the breath con-
densatebefore analysis.Theperiod of storageby freezing
the breath condensate varies from 6h up to 1month
(3^6).Detailed data on the actual stability of H2O2 con-
centrations are not provided inmost studies.The advan-
tage of storage of the breath condensates is that the
FIG. 1. Collecting device: a mouthpiece is connected to a valve
system and the expiration valve is connected to the top of a
0?4m high glass bulbcooler, which is constantly cooled by a re-
verse stream of ice water (01C). At the base of the bulbcooler
the condensate is collected in a glass container.To the side open-
ingoftheT-glass tube atthebase ofthebulbcooler, an air volume
meter (Ohmeda type 5410) is attached.To avoid condensation in
thevalve system, the systemisheatedbya fanproducinga diver-
ging streamof hot air with aminimumtemperature of 421C.
198 RESPIRATORYMEDICINEcondensates need not be analysed immediately, which is
a time-consuming procedure. Furthermore all measure-
ments can be performed using one calibration curve,
which ismore reliable.
In view of the above mentioned problems, we con-
ducted this study with the following research questions.
Firstly, can we adapt the breath condensate collecting
devices described in literature in order to develop amore
e⁄cientdevice? Secondly, arewe able to improve the ex-
isting analytical methods to establish a lower detection
limit? Thirdly, is the procedure reproducible in a group
of COPD patients? Finally, is the H2O2 concentration in-
£uencedby freezing the condensate ^reagentmixture at
701C?
MATERIALSANDMETHODS
Patients
We performed this study in a population of COPD pa-
tients, because in most healthy persons the H2O2 con-
centration is below the H2O2 detection limit.The H2O2
concentration is signi¢cantly higher in COPD patients
(3,13).Twenty stable COPDpatientswere recruited from
the outpatient clinic of a large non-academic teaching
hospital. Inclusion criteria were: (1) a diagnosis of COPD
according to the ERS criteria (14); (2) smokers or ex-smo-
kers with at least 10 pack-years; (3) age between 40 and
85 years; (4) a forced expiratory volume in 1sec (FEV1)
o60% of predicted and FEV1 vital capacity (VC) ratio
o60%, with a reversibility of less than 12% of predicted
after taking a bronchodilator. Patients used their own
bronchodilators, but any inhaled corticosteroids and/or
acetylcystein were discontinued for at least 4weeks
prior to the study.The study was approved by the local
ethics committee. All patients gave informed consent.
Twenty stable COPD patients (19 male, mean age 65
years, mean FEV1 48% predicted) from the outpatient-
clinic were included in the study. Eight patients were
current smokers and 12 were ex-smokers. Patient
characteristics are shown inTable1.
Collecting device
The collecting device consisted of a mouthpiece con-
nected to a valve system. The expiration valve wasTABLE 1. Characteristics of studypopulation (n=20)
Age (years, mean7SD) 6576?8
Sex (male/female) 19/1
Smoking status (smoker/ex-smoker) 8/12
Pack-years (PY, mean7 SD) 39712?5
FEV1 (% of predicted, mean7 SD) 4877?25
FEV1/FVC (%, mean7 SD) 4978connected to the top of a 0?4 m high glass bulbcooler
with an inside air volume of155ml, whichwas constantly
cooled by a reversed stream of ice water (01C). At the
bottom of the bulbcooler the condensate was collected
in a glass container. An air volumemeter (Ohmeda type
5410) was attached to the side opening of aT-glass tube
at thebottomof thebulbcooler.To avoid condensation in
the valve system, the systemwas heatedby a fan.The fan
produced a diverging stream of hot air with a minimum
temperature of 421C, it was placed approximately 0?5m
from the valve system.The bulbcooler was £ushed with
distilled water (not containing H2O2) before and after
each test to remove any H2O2 residue from the previous
test (Fig.1).
Because we suspected that £ushing the bulbcooler
with distilled water before each test might dilute the
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H2O2 concentration, we also investigated this e¡ect by
performing the following tests.
The bulbcooler was £ushed with physiologic saline
(0?9%) before performing a breath test.The condensate
was obtained in fractions of 0?3ml and the sodium con-
centration of these fractions was measured bymeans of
a selective sodium electrode. Using this method we
could determine how much condensate had to be col-
lected in order to wash out all traces of the saline left
behind on the glass wall after £ushing the bulbcooler
with saline. By comparing the subsequent sodium con-
centrations, it was a⁄rmed that the water¢lm on
the inside wall of the glass bulbcooler was replaced
for 95% after the formation of 1?8ml of condensate
during the breath test. The actual collected condensate
volumes varied in our patients from 1?85 to 4?75ml.
This meant that the water¢lm, formed after £ushing
the cooler, was almost completely replaced by
breath condensate at the end of each test and that the
H2O2 concentration of the condensate had to be cor-
rected for the dilutionwith thevolume of thewater¢lm,
which was formed by £ushing the cooler before each
test.
To determine the degree of dilution, thevolume of the
water¢lm (aml) formed in the cooler after £ushing had
to bemeasured.We determined thisby £ushing the cool-
er againwith a NaCl containing solution (1500mmol l1),
followed by £ushing the cooler with a ¢xed amount of
distilled water (5ml). Subsequently, the sodium concen-
tration of the solution collected at the base of the bulb-
cooler was measured (bmmol l1) and compared to the
initial concentration of the NaCl.The volume of the ¢lm
in the bulbcooler could be calculated by: a=b 5/1500.
With thismethod the volume of thewater¢lm on the in-
side of thebulbcooler was determined to be 0?35ml.This
was used for correcting the H2O2 concentration of the
breath condensates (condensate volume c+0?35/c
measured H2O2 concentration).
The condensate of three random patients was
checked for amylase in order to exclude contamination
of the breath condensate by saliva. An enzymatic colori-
metric assay for the quantitative determination of a-
amylase in human serum, plasma and urine, according to
the recommendations of the IFCC, was used.
Analysis of H2O2 in the condensate
P-hydroxyphenylacetic acid 1?0mmoll1 from Fluka AG
(Bormen, Belgium) was used for the analysis, together
with horshe radish peroxidase 15Umll1 and catalase
160Umll1 from Sigma Chemical Co (St Louis, MO,
U.S.A.).DistilledwaterTKF7114was obtained fromBaxter
BV (Utrecht,TheNetherlands) and thehydrogenperoxide
107209.1000 fromMerck KgaA (Darmstadt,Germany).After collection of the condensate, its volume was
measured. Subsequently, to 250ml of breath condensate,
10ml p-hydroxyphenylacetic acid and10ml15Ul1 horse-
radish peroxidasewere addedwithin 30min after collec-
tion (15).
The £uorescence of the reaction product (dimer 2,2’-
dihydroxybiphenyl-5,5’-diacetate) wasmeasuredwith an
automated sampler, £ow injection and scanning £uores-
cence detector from Waters, Millipore Corporation
(Milford, MA, U.S.A.), with an excitation wave length of
295 nm and an emissionwave length of 405nm.The reac-
tion product was injected into the £uorimeter which
produced a curve and the £uorescence was presented
by the area under the curve. Besides a blank measure-
ment, several standard concentrations of H2O2 were
measured, using concentrations of up to 3?0mmol l1.
Additionally, the detection limit was determined by
measuring several times the standard H2O2 concentra-
tion of 0?0mmol l1 and calculating the mean and
standard deviation of the samples, with the detection
limit being 3 SD. Each collected condensate was ana-
lysed in duplicate andmean values were used for further
analysis.
To determine the speci¢city of the assay, in a pilot
study of 17 condensate samples, catalase was added to
convert H2O2 to water, and the H2O2 concentration
wasmeasured again.
Procedure of the breath test
All patients performed the breath tests in the morning,
after they had taken their medication. They refrained
from smoking after midnight of the preceding day, since
cigarette smoke contains oxidants. Before the test,
patients rinsed their mouth with tap water to avoid
contamination of the breath condensate.They breathed
in the collecting device twice for a period of 10min,
while wearing a nose-clip. After both tests the conden-
sate volumes and total exhaled volume (EAV) weremea-
sured.
To test the reproducibility of the whole procedure,
the H2O2 concentration measured during the ¢rst test
was compared to the concentration measured during
the second test.
Stability of the reaction product
Several condensate-reagent mixtures were frozen at
701C. In a pilot study of 34 condensates, the stability
of the condensate-reagentmixturewas tested (the con-
densates were also collected in stable COPD patients
not included in the study population). The £uorescence
of the reaction product was measured directly and 10,
20 and 40 days after storage at701C.
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FIG. 3. Bland-Altmanplot: theH2O2 concentrationmeasured
during the ¢rst and second test, the plots represent di¡erence
against mean. Lines represent meandi¡erence (^ - )^ and
2 SDdi¡erence (F).
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200 RESPIRATORYMEDICINEStatisticalmethods
Results are expressed asmean7SEM.Thepaired studentt-
test was used to compare the results obtained from the
¢rst and second test, with a=0?05.The relation between
themeanvalues of the ¢rst and second test and the di¡er-
ence between the two tests was presented in a Bland^
Altman plot.The relation between the EAV and conden-
sate volumewas expressed as correlation coe⁄cient.The
meanH2O2 concentrationof the samplesmeasured atday
o was compared with the concentration at day10, day 20
and day 40 using the paired student t-test (ao0?05).
RESULTS
Collecting device
The mean condensate volume collected in 10min was
2?870?14ml after the ¢rst test and 3?270?15ml after
the second test.The volume was signi¢cantly higher the
second time (Po0?01).Three condensates were checked
for the presence of amylase; no amylasewas found.
Validation of the analysis of H2O2 in the
condensate
A calibration curve was constructed, with a range up to
3?0mmol l1 (Fig. 2).The detection limit was determined
to be 0?02mmol l1. After adding catalase to 17 separate
condensates, the mean H2O2 concentration decreased
from 0?25mmol l1to below the detection limit.
Reproducibility of the breath test
The H2O2 concentration measured during the ¢rst
breath test was 0?2270?03mmol l1 and during the0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
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FIG. 2. Calibration curve obtained with standard amounts of
H2O2. H2O2 concentration is plotted against area under the
curvemeasuredby the £uorimeter.
FIG. 4. The correlation between the total exhaled air volume
and condensate volume of the ¢rst and second breath test.The
correlations are shownfromthe ¢rsttest (&) (r= 0?90) andthe
second test (&) (r= 0?95).second test 0?2170?03mmol l1.Therewas no signi¢cant
di¡erence between both measurements (P=0?7).
The reproducibility is also shown in a Bland^Altman
plot (Fig. 3).There was no signi¢cant di¡erence in H2O2
concentration between current smokers and ex-smo-
kers.
The mean EAV was 108?667?58l after the ¢rst test
and 103?476?32l after the second test. The di¡erence
was signi¢cant (P=0?04). The correlation (r) between
the EAV and the volume of the collected condensate
was 0?90 (Po0?01) during the ¢rst test and 0?95
(Po0?01) during the second test (Fig. 4).
Days0 10
0.2
0.4
0.6
0.8
1.0
0
H
O
 
co
n
ce
n
tr
at
io
n 
(
m
o
l l
)
2
2

−
1
(a)
Days0 20
0.2
0.4
0.6
0.8
1.0
0
H
O
 
co
n
ce
n
tr
at
io
n 
(
m
o
l l
)
2
2

−
1
(b)
Days0 40
0.2
0.4
0.6
0.8
1.0
0
H
O
 
co
n
ce
n
tr
at
io
n 
(
m
o
l l
)
2
2

−
1
(c)
FIG. 5. TheH2O2 concentrationmeasuredimmediatelyandafter freezing thereactionproductfor aperiodof10 (a), 20 (b) or 40 days (c).
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The H2O2 concentration in 15 frozen reaction products
was measured immediately and after a period of10 days
[Fig. 5(a)]. Twelve reaction products were measured di-
rectly and 20 days later [Fig. 5(b)], and seven were re-
peated after 40days [Fig. 5(c)].The H2O2 concentration
appeared to remain stable over all these time periods.
There was no signi¢cant di¡erence in mean H2O2
concentration between day 0 (0?4470?19mmoll1)
and day 10 (0?4370?18mmoll1: P=0?56), on day 0
(0?4870?13mmol l1) and day 20 (0?4770?14mmol l1),
or day 0 (0?3970?16mmol l1 and day 40
(0?3870?17mmol l1).
DISCUSSION
The present study shows that the collecting device used
in this procedurewas able to collect a su⁄cient amount
of condensate within a smaller time period. A lower de-
tection limit formeasuringH2O2 concentration inbreath
condensate was obtained compared to other studies.
The reproducibility of thewholeprocedurewas accepta-
ble; there was no signi¢cant di¡erence in H2O2 concen-
tration between tests 1 and 2. Finally, the H2O2
concentration didnot appear to be in£uencedby storage
of the reaction product at 701C for a period up to
40days.
Initially, we used other constructions for collecting
breath condensate that havebeen described in literature
(3,4,7). A condense chamber and subsequently a sphere
were cooledwith solid carbondioxide, but thevolume of
the obtained condensate was very variable. This was
probably caused by the inability to establish su⁄cient
contact time between the exhaled air and the cooling
system. Therefore the amount of condensate collectedwas never more than 1ml after 15min of breathing.
Antczak (9) and Nowak (4) used a glass tube cooled by
a package of ice andwere able to collect 2^5ml conden-
sate in 20min. With our current device we collected
2^5ml condensate in only10minbymeans of a glassbulb-
cooler cooled by a reverse stream of ice water, which
leads to better condensation.
In accordance with other investigators the patients
were instructed to rinse theirmouth before each breath
test to avoid contamination of the breath condensate by
saliva. Unlike others, we did not use a separate saliva
trap, because the device was constructed in such a way
that the exhaled air went up through the valve system
before entering the cooled bulbcooler. Indeed, no amy-
lasewas found.
Recently, Schleiss et al. showed that exhaled H2O2 de-
pends on expiratory £ow rates (18). In our study we did
not control expiratory £ow rates. There was a signi¢-
cant, but small di¡erence in EAV between the ¢rst
(108?6l) and second test (103?4l).Themean £owrate dur-
ing the ¢rst test was 181ml sec1 and during the second
test was 171mlsec1. However, H2O2 concentrations
were similar in the two tests (0?21and 0?22mmol l1, re-
spectively).
To ensure that no H2O2 was left behind from the pre-
vious patients, the bulbcooler was cleaned before and
after each breath test.We cleaned the cooler with dis-
tilledwater.
No tap water was used in order to avoid contamina-
tionwith particles that could in£uence the £uorescence.
Flushing the cooler with distilled water before each test
caused dilution of the obtained condensate by distilled
water from the water¢lm, so we corrected the H2O2
concentration for this dilution. The correcting factor
could have been avoided by heating the collecting device
to make all H2O2 disappear. However, the heating and
202 RESPIRATORYMEDICINEcooling down of the collecting devicewouldbe time con-
suming and thus unpractical, since we wanted to mea-
sure several patients on the same day with an interval
of only 30min.
Looking at the method of analysis described in litera-
ture to determine the H2O2 concentration in the breath
condensate, twomethods have been used in general; the
spectrophotometrical method according to Gallati and
Pracht (16) and the £uorimetrical method according to
Hyslop and Sklar (15) or Ruch (17). Sznajder (5), Loukides
(7) and Dekhuijzen (3) used the spectrophotometrical
method and obtained a detection limit of 0?1mmol l1.
Others, using a £uorimetrical method, found detection
limits of 0?083^0?1mmoll1 (4,6,8,9).We performed the
analysis of the breath condensate according to Hyslop
and Sklar, and were able to establish a detection limit of
0?02mmoll1.
This is lower than the detection limits described by
others using the same method. This could be explained
by the fact that the £uorimeter reads the degree of
£uorescence of the condensate ^reagens mixture and
this is converted into a concentration. Usually a cuvet
containing the condensate ^reagens mixture is placed
into the £uorimeter.We chose to use £ow injection of
themixturewith £uorimetrical detection instead, which
may be more sensitive (although comparative data are
lacking).
Our test procedure formeasuring exhaled H2O2 con-
centration proved to be reproducible.There was no sig-
ni¢cant di¡erence between the H2O2 concentration in
the ¢rst and second test.Whenwe consider the Bland^
Altman plot of these tests, all but one patient showed a
di¡erence between the two tests of less than 2 SD from
the mean di¡erence. In this patient the relatively great
di¡erencemightbe explainedby a delaybetween the col-
lection of the condensate and its analysis.
In this study we found a mean H2O2 concentration of
0?21mmol l1 in stable COPD patients. Dekhuijzen et al.
found a similar mean H2O2 concentration in stable
COPD patients (3). The concentration measured by
Nowak et al. was somewhat higher; 0?48mmoll1 (4).
Other investigators measured the H2O2 concentration
in asthma patients, in these patients the H2O2 concen-
tration varied from 0?6 to 0?8mmoll1 (6,9,12).
Therewas a di¡erence in EAVand condensate volume
during the ¢rst and second test, which can be explained
by variation within the patients themselves. It proved to
be di⁄cult to perform several breath tests with exactly
the same tidal volume and frequency.Themean EAVwas
lower after the second test, while the condensate vo-
lume was higher. A possible explanation is that di¡erent
breathing patterns cause di¡erent VD/VT ratios (dead
space volume/tidal volume). The humidity of the VD is
lower than thatof theVT,which could lead to a di¡erence
inhumidityof the exhaled air.However,EAVand conden-
sate volumewere strongly correlated both times.Finally, storage of the reaction product for at least 10
days at701Cwas possiblewithout any changes inH2O2
concentration and appeared to have virtually no in£u-
ence on themeasuredH2O2 concentration up to 40days
(Fig.4).Others have studied thepossibilities of storage of
the breath condensate and found that the H2O2 concen-
tration in the condensate remained stable for only a few
hours to several days.This could be explainedby the fact
that they froze the breath condensate instead of the re-
action product, as we did in the present study.
In conclusion,wewere able to develop amore e⁄cient
breath condensate collecting device, by adapting collect-
ing devices described in literature. By adapting the £uor-
imetrical method of analysis we could lower the
detection limit.The test procedure proved to be repro-
ducible and easy to perform. In addition, the H2O2 con-
centration after storage of the breath condensate
appeared to remain stable for a period up to 40days.
These ¢ndings may facilitate the application of this
method in future prospective andmulti-centre studies.
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